{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:29:00Z","timestamp":1787887740199,"version":"build-2784847793"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The worldwide pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unprecedented and the impact on public health and the global economy continues to be devastating. Although early therapies such as prophylactic antibodies and vaccines show great promise, there are concerns about the long-term efficacy and universal applicability of these therapies as the virus continues to mutate. Thus, protein-based immunogens that can quickly respond to viral changes remain of continued interest. The Spike protein, the main immunogen of this virus, displays a highly dynamic trimeric structure that presents a challenge for therapeutic development. Here, guided by the structure of the Spike trimer, we rationally design new Spike constructs that show a uniquely high stability profile while simultaneously remaining locked into the immunogen-desirable prefusion state. Furthermore, our approach emphasizes the relationship between the highly conserved S2 region and structurally dynamic Receptor Binding Domains (RBD) to enable vaccine development as well as the generation of antibodies able to resist viral mutation.<\/jats:p>","DOI":"10.3389\/fimmu.2021.660198","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T03:02:15Z","timestamp":1619060535000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design"],"prefix":"10.3389","volume":"12","author":[{"given":"Timothy P.","family":"Riley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruozhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof P.","family":"Bzymek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Partin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhulun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Manzanillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1000197","DOI":"10.1371\/journal.ppat.1000197","article-title":"Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway","volume":"4","author":"Sui","year":"2008","journal-title":"PloS Pathog"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PloS Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.002386","article-title":"A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing","author":"Gordon","year":"2020","journal-title":"bioRxiv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.16.099317","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","author":"Cai","year":"2020","journal-title":"bioRxiv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.007","article-title":"Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans","volume":"43","author":"Garces","year":"2015","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/.74.11.5091-5100.2000","article-title":"Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits","volume":"74","author":"Sanders","year":"2000","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.17.8875-8889.2002","article-title":"Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1","volume":"76","author":"Sanders","year":"2002","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15701","DOI":"10.1038\/s41598-018-36918-8","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"Kirchdoerfer","year":"2018","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.03.129817","article-title":"Closing coronavirus spike glycoproteins by structure-guided design","author":"McCallum","year":"2020","journal-title":"bioRxiv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.28.121533","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1101\/2020.06.14.150607","article-title":"Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis","volume":"34","author":"Herrera","year":"2020","journal-title":"bioRxiv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00547-5","article-title":"Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike","volume":"28","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.celrep.2020.108630","article-title":"D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1\/S2 Junction","volume":"34","author":"Gobeil","year":"2021","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00547-5","article-title":"Cold sensitivity of the SARS-CoV-2 spike ectodomain","volume":"28","author":"Edwards","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0479-4","article-title":"Controlling the SARS-CoV-2 spike glycoprotein conformation","volume":"27","author":"Henderson","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826","article-title":"Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0483-8","article-title":"Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation","volume":"27","author":"McCallum","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.07.006","article-title":"Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2","volume":"7","author":"Hu","year":"2020","journal-title":"Genes Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0478-5","article-title":"A thermostable, closed SARS-CoV-2 spike protein trimer","volume":"27","author":"Xiong","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0827","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.17.20176651","article-title":"RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study","author":"Walsh","year":"2020","journal-title":"medRxiv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2548-6","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.092619","article-title":"Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals","author":"Robbiani","year":"2020","journal-title":"bioRxiv"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop","volume":"432","author":"Jaimes","year":"2020","journal-title":"J Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.21.214759","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"Garces","year":"2014","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.1038\/s41598-020-70812-6","article-title":"Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity","volume":"10","author":"Islam","year":"2020","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61312.sa2","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","author":"Weisblum","year":"2020","journal-title":"bioRxiv"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1038\/s41467-020-17371-6","article-title":"Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein","volume":"11","author":"Fan","year":"2020","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e20161","DOI":"10.1371\/journal.pone.0020161","article-title":"RosettaScripts: a scripting language interface to the Rosetta macromolecular modeling suite","volume":"6","author":"Fleishman","year":"2011","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"Elife"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.660198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T03:02:18Z","timestamp":1619060538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.660198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2021.660198"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.660198","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"article-number":"660198"}}